Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SPEPHARM NORDIC ApS
APS
In liquidation
CVR 31176786
Stamholmen 151, 2650
Hvidovre
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2008 · 18 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
SPEPHARM NORDIC ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2012
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2012
Income statement
DKK thousands
Item
2012
Gross profit
155
Staff expenses
-135
EBITDA
21
Depreciation & amort.
-1
EBIT
20
Net financials
-1
Profit before tax
Balance sheet
DKK thousands
Item
2012
Total assets
134
Equity
90
Long-term debt
0
Short-term debt
44
Total debt
44
Financial ratios
5-year trend
EBITDA margin (of gross profit)
13.3%
This company
2012
2012
Equity ratio
67.4%
This company
38.2%
Market median
Annual reports & filings
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
More on SPEPHARM NORDIC ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
19
Tax
5
Net profit
14
+76% vs market
2012
2012
Return on equity
15.8%
This company
18.4%
Market median
+14% vs market
2012
2012
Net profit margin (of gross profit)
9.2%
This company
2012
2012
Asset turnover (of gross profit)
1.16×
This company
2012
2012
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
2012
2012
